|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Accounts receivable (net of allowances for doubtful accounts of $9,261 and $8,415, respectively) | |||||||||||||||||||
| Deferred income taxes | |||||||||||||||||||
| Other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Trademarks and tradenames | |||||||||||||||||||
| Other intangible assets, net | |||||||||||||||||||
| Deferred income taxes | |||||||||||||||||||
| Other non-current assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and equity | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Current portion of long-term debt | |||||||||||||||||||
| Current portion of operating lease liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Long-term operating lease liabilities | |||||||||||||||||||
| Deferred income taxes | |||||||||||||||||||
| Other non-current liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Shareholders' equity (deficit): | |||||||||||||||||||
| Common shares ($0.0025 par value; 560,000,000 shares authorized; 128,326,915 shares and 128,229,030 shares issued; 126,523,035 shares and 126,436,176 shares outstanding as of March 31, 2019 and December 31, 2018, respectively) | |||||||||||||||||||
| Additional paid in capital | |||||||||||||||||||
| Treasury shares, at cost (1,803,880 shares and 1,792,854 shares as of March 31, 2019 and December 31, 2018, respectively) | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Total shareholders' equity (deficit) | |||||||||||||||||||
| Equity attributable to non-controlling interest in subsidiaries | |||||||||||||||||||
| Total equity (deficit) | |||||||||||||||||||
| Total liabilities and equity | |||||||||||||||||||
Loading...
